Both in Pharmaceuticals
Cue Biopharma vs Journey Medical
Over the past year CUE returned −8.3% and DERM returned −47.4%; their daily moves had a correlation of 0.04.
CUE −8.3% DERM −47.4%Growth of $1, one year, split-adjusted
| Metric | CUE | DERM |
|---|---|---|
| Price | $19.84 | $4.73 |
| Market cap | $144.1M | $133.5M |
| Today | −4.89% | +1.94% |
| 1 month | −14.3% | −23.2% |
| 6 months | −41.6% | −9.2% |
| Year to date | +116.5% | −38.7% |
| 1 year | −7.8% | −44.5% |
| Revenue growth (YoY) | +166.7% | +18.9% |
| Gross margin | 100.0% | 65.6% |
| Net margin | −1943.2% | −1.7% |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | 2.0× |
| Net cash | $16.4M | -$245.0K |
| Dividend yield | — | — |
| Volatility (60d) | 137.7% | 64.5% |
| Short % of float | 12.2% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).